| IM | Supported by an NHS Education for Scotland/Chief Scientist Office Postdoctoral Clinical Lectureship (PCL 17/07) |
| M G-D | None |
| CH | None |
| BJMN | None |
| CCL | Declares receiving consultancy fees and/or research grants from Amgen, AstraZeneca, MSD, Novartis, and Servier; grant funding from European Union Horizon 2020 IMI, MRC, British Heart Foundation, EFSD. |